GLENMEDE TRUST CO NA - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,636
-79.1%
20,0000.0%0.00%
Q2 2023$12,6000.0%20,0000.0%0.00%
Q1 2023$12,600
-2.9%
20,0000.0%0.00%
Q4 2022$12,982
-61.8%
20,0000.0%0.00%
Q3 2022$34,000
+41.7%
20,0000.0%0.00%
Q2 2022$24,000
+84.6%
20,000
-2.9%
0.00%
Q1 2022$13,000
-40.9%
20,6060.0%0.00%
Q4 2021$22,000
-40.5%
20,6060.0%0.00%
Q3 2021$37,000
-28.8%
20,606
+3.0%
0.00%
Q2 2021$52,000
+2500.0%
20,000
+2122.2%
0.00%
Q2 2020$2,0000.0%900
+42.0%
0.00%
Q2 2014$2,0000.0%6340.0%0.00%
Q1 2014$2,0000.0%6340.0%0.00%
Q4 2013$2,0006340.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders